Suchergebnisse - "Motoi, Noriko"

PubPharm (165)

1

STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-γ-induced Apoptosis in Urothelial Cancer

enthalten in: Anticancer research | 2024

von Fuchizawa, H. | Ando, K. | Motoi, N. | +10

2

An algorithm-based technique for counting mitochondria in cells using immunohistochemical staining of formalin-fixed and paraffin-embedded sections

enthalten in: Journal of cancer research and clinical oncology | 2024

von Sakashita, M. | Motoi, N. | Yamamoto, G. | +8

3

Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments

enthalten in: Cancer science | 2024

von Fukuda, H. | Arai, K. | Mizuno, H. | +38

4

Prevalence and diagnostic significance of non-invasive follicular thyroid neoplasm with papillary-like nuclear features in Japan-A multi-institutional study

enthalten in: Pathology international | 2024

von Hirokawa, M. | Ito, M. | Motoi, N. | +7

5

Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer

enthalten in: Scientific reports | 2024

von Ohashi, K. | Nishito, Y. | Fukuda, H. | +11

6

Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma

enthalten in: Nature communications | 2023

von Haga, Y. | Sakamoto, Y. | Kajiya, K. | +18

7

Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer

enthalten in: British journal of cancer | 2023

von Shirasawa, M. | Yoshida, T. | Shiraishi, K. | +20

ErratumIn: Br J Cancer. 2023 Nov 3;:. - PMID 37923915

8

Positive regulatory loop of platelet-derived growth factor DD-induced STAT3 activation is associated with poor prognosis in advanced urothelial carcinoma

enthalten in: Biochemical and biophysical research communications | 2023

von Ando, K. | Kurashina, R. | Motoi, N. | +10

9

Whole Exome Sequencing of Thymoma Patients Exhibiting Exceptional Responses to Pemetrexed Monotherapy

enthalten in: Cancers | 2023

von Tanaka, T. | Goto, Y. | Horie, M. | +11

10

Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations

enthalten in: Cancer research communications | 2023

von Aoki, K. | Nishito, Y. | Motoi, N. | +38

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]